Non-secreting myeloma
Neretto, G.; Giovanelli, E.; Bianco, G.; Caligaris, F.
Minerva Medica 69(19): 1309-1314
1978
ISSN/ISBN: 0026-4806 PMID: 662158 Document Number: 136735
On the basis of a personal observation, the cases of "non secretory" multiple myeloma reported in the literature are reviewed. A myeloma classification based upon the production and excretion of monoclonal proteins by neoplastic plasmacells is presented together with an evaluation of the different possible pathogenetic mechanisms. The diagnostic criteria of "non secretory" myeloma are discussed and its main clinical problems analyzed.
Document emailed within 1 workday
Related Documents
Bonfanti, S.; Avanzi, C. 1991: A case of IgM-secreting myeloma Minerva Medica 82(9): 599-601Andreeva, N.E.; Litvinenko, A.I.; Iakovleva, S.V.; Sokolova, O.M. 1992: A myeloma secreting immunoglobulin M (a report of 2 cases) Terapevticheskii Arkhiv 64(10): 39-42
Bernardeschi, P.; Bonechi, I. 1988: Non-secreting anaplastic myeloma. Description of a primary case Recenti Progressi in Medicina 79(1): 30-31
Eton, O.; Scheinberg, D.A.; Houghton, A.N. 1989: Establishment and characterization of two human myeloma cell lines secreting kappa light chains Leukemia 3(10): 729-735
Qi, Y.; Moyana, T.; Chen, Y.; Xiang, J. 1996: Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RM4/IFN-tau Human Antibodies and Hybridomas 7(1): 21-26
Peña Yáñez, A.; Bermúdez, J.M.; Raya, J.; Salmerón, J.; Palomo, S. 1976: Non-secreting myeloma with myelomatous kidney. a case of parciall resistance to melphalen and cyclophosphamide with favorable response to nitrosourea combination Revista Clinica Espanola 143(6): 543-550
Kearney, J.F.; Radbruch, A.; Liesegang, B.; Rajewsky, K. 1979: A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines Journal of Immunology 123(4): 1548-1550
Xiang, J.; Moyana, T. 1998: Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo Cancer Gene Therapy 5(5): 313-320
McKeever, P.E.; Neiders, M.E.; Nero, G.B.; Asofsky, R. 1979: Murine plasma cells secreting more than one class of immunoglobulin. VI. Secretion of completely assembled IgG2b and IgA molecules with segregated heavy chains and free light chains by spontaneous myeloma SAMM 368 in culture Journal of Immunology 122(5): 1972-1977
Bassetti, M.; Brina, M.; Spada, A.; Giannattasio, G. 1989: Somatomammotrophic cells in GH-secreting and PRL-secreting human pituitary adenomas Journal of Endocrinological Investigation 12(10): 705-712
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Leinonen, P.; Somer, T. 1988: Light-chain myeloma and non-secretory myeloma--problems in di- agnosis and associated paraproteins Duodecim; Laaketieteellinen Aikakauskirja 104(18): 1466-1470
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
G.Mead, P.; H.D. Carr-Smith; M.Drayson, T.; A.R. Bradwell 2003: Detection of Bence Jones Myeloma and Monitoring of Myeloma Chemotherapy UsingImmunoassays Specific for Free Immunoglobulin Light Chains Clinical Laboratory 49(1-2): 25-27
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Crozier, F.; Lechevallier, E.; Eghazarian, C.; André, M.; Sammama, D.; Wilshire, P.; Vidal, V.; Pascal, P.; Bartoli, J.M. 1999: Retroperitoneal non-secreting paraganglioma Journal de Radiologie 80(2): 150-152